What's Changed? Tanzania is strengthening the use of regulatory reliance as part of its approach to the marketing authorisation of human medicinal products. On 30 June 2026, the Tanzania Medicines and Medical Devices Authority (TMDA) issued a public notice outlining its Regulatory Reliance Pathways for Marketing Authorisation of Human Medicinal Products. The notice was published by TMDA on 3 July 2026. Regulatory reliance allows a national regulatory authority to consider and